Your browser doesn't support javascript.
loading
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
Wilhelm, Stefan; Boess, Frank G; Hegerl, Ulrich; Mergl, Roland; Linden, Michael; Schacht, Alexander; Schneider, Edith.
Affiliation
  • Wilhelm S; Medical Department, Neuroscience, Lilly Deutschland GmbH, Werner-Reimers-Strasse 2-4, 61352 Bad Homburg, Germany. wilhelm_stefan@lilly.com
Expert Opin Drug Saf ; 11(5): 699-711, 2012 Sep.
Article in En | MEDLINE | ID: mdl-22712514
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Selective Serotonin Reuptake Inhibitors / Depression / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Selective Serotonin Reuptake Inhibitors / Depression / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: Germany Country of publication: United kingdom